Chief Scientific Officer (CSO)
Mattek
Ashland, Massachusetts
Dr. Seyoum Ayehunie is currently Chief Scientific Officer at MatTek Corporation, a BICO company, Ashland, MA, and leads the R&D group at MatTek. He has developed multiple in vitro primary human cell-based organotypic tissue models that can be incorporated into the MPS platforms that can be used for drug safety and efficacy studies. In addition, he has received more than 20 Small Business Innovation Research (SBIR Phase I and Phase II) grant awards from the National Institute of Health (NIH) and the Department of Defense (DoD). Dr. Ayehunie has served as permanent member of NIH Study Sections. He has more than 50 publications in refereed journals to his credit and has made several presentations in international conferences and collaborated with academic institutions.
Prior to joining MatTek, Dr. Ayehunie, who received his PhD from the Karolinska Institute, Stockholm, Sweden, did his post-doctoral fellowship at Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. At Harvard Dr. Ayehunie was involved in HIV vaccine research and received the Fogarty International and NIH fellowship awards and also appointed as an instructor of Medicine.
Hot Topic: Challenges and Opportunities of in vitro Assays and Organ-On-A-Chip
Wednesday, October 25, 2023
10:00 AM – 11:00 AM ET